Stockholders' Equity (Deficit) - Schedule of Restricted Stock Units Activity (Details) |
9 Months Ended |
|---|---|
|
Mar. 31, 2021
$ / shares
shares
| |
| Equity [Abstract] | |
| Number of Shares, Outstanding, Beginning balance | shares | |
| Number of Shares, Granted | shares | 134,865 |
| Number of Shares, Forfeited and cancelled | shares | (6,542) |
| Number of Shares, Outstanding, Ending balance | shares | 128,323 |
| Weighted Average Grant date Fair Value, Outstanding, Beginning balance | $ / shares | |
| Weighted Average Grant date Fair Value, Granted | $ / shares | 8.88 |
| Weighted Average Grant date Fair Value, Forfeited and cancelled | $ / shares | 8.88 |
| Weighted Average Grant date Fair Value, Outstanding, Ending balance | $ / shares | $ 8.88 |
| Weighted Average Remaining Contract Term (years), Outstanding, Ending balance | 2 years 10 months 28 days |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|